LabGenius

OverviewSuggest Edit

LabGenius engages in the discovery of new biological molecules with artificial intelligence, automation, and synthetic DNA. The Company's mission is to harness evolution with AI to develop radically new materials. Using its proprietary DNA library assembly capability, in conjunction with ultra-high throughput screening, AI and robotics, LabGenius plans to unlock a new wave of bio-augmented materials, with applications including energy, adhesives, and composite materials.


TypePrivate
Founded2012
HQLondon, GBMap
Websitelabgeni.us
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2021)46
Cybersecurity ratingBMore

Key People/Management at LabGenius

James Field

James Field

Founder & Chief Executive Officer
Nan Li

Nan Li

Board Director
Zavain Dar

Zavain Dar

Board Director
Irina Haivas

Irina Haivas

Board Director
Ante Patrk

Ante Patrk

Head of Finance and Operations
Show more

LabGenius Office Locations

LabGenius has an office in London
London, GB (HQ)
100 Drummond Rd, Bermondsey
Show all (1)

LabGenius Financials and Metrics

Summary Metrics

Founding Date

2012

LabGenius total Funding

$28.7 m

LabGenius latest funding size

$15 m

Time since last funding

3 months ago

LabGenius investors

iNovia Capital, Tom McInerney, Atomico, Lux Capital, Obvious Ventures, Charlie Songhurst, Berggruen Holdings, Patrick Pichette, Backed VC, Kindred, Felicis Ventures, Beast Ventures, Tiny Super Computer Investment Company, System.One, Nathan Benaich, Champion Hill Labs, Kindred Capital, Chris Gibson, Air Street Capital
LabGenius's latest funding round in October 2020 was reported to be $15 m. In total, LabGenius has raised $28.7 m
Show all financial metrics

LabGenius Revenue

Cash (31-Aug-2018)

2.8m
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

6.046.9k51.2k2.8m

Accounts Receivable

999.0134.7k64.0k

Current Assets

294.053.2k134.7k128.8k3.8m
show all
FY, 2014

Financial Leverage

-0.1 x
Show all financial metrics

LabGenius Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

Learn more about our premium products
SecurityScorecard logo

LabGenius Online and Social Media Presence

LabGenius's Trends

Embed Graph

LabGenius News and Updates

October 29, 2020

LabGenius closes $15 million Series A extension led by Atomico, brings round to $25 million

London-based LabGenius, a biotech company using machine learning to develop new therapeutics, has secured a $15 million extension of its Series A, bringing the round’s total to $25 million. Atomico led the investment, and partner Irina Haivas will join the startup’s board. Other investors include th…
October 23, 2019

London-based LabGenius raises €11.5 million to scale its AI-driven drug discovery platform

LabGenius has announced today that it has raised over €11.5 million in its Series A funding round. Founded in 2012, LabGenius is a drug discovery company that is using artificial intelligence (AI), robotic automation, and synthetic biology to discover novel protein therapeutics. The company has deve…
October 23, 2019

New Breed Of Biotech Investors Show Their Hand With $10 Million Investment In London Startup LabGenius

In leading the $10 billion investment in LabGenius, two U.S. venture capital funds Lux Capital and Obvious Ventures reveal a biotech investing strategy not seen from the old guard of life science financing.

LabGenius Blogs

January 18, 2021

An article on my work / Un article sur mon travail

Build software, better is an online place for dialogue and exchange between leaders, managers and developers. It was founded in 2020 by Jeff Haynie and aims at helping people from all over the world communicate in these weird times, mostly on the topics of programming and management to “build better…
January 05, 2021

Origami #1: the Crane

You probably know of origami, the art of paper folding. So how would you like to see some 2d-animated origami models with step-by-step instructions to go along with the movie? Although origami is most often associated with the Japanese tradition, nowadays the term is used for virtually all forms of …
December 14, 2020

A couple of new musical covers

Here are some new covers with piano, guitar and vocals! And as usual, some morse code-inspired artworks to go along with the music 🙂 Stay With Me (Cover) Sam Smith- In the Lonely Hour, 2014 Sway (Cover) Dean Martin - Hey, Brother, Pour the Wine, 1954  
November 11, 2020

A small musical cover

Today, here is a new cover of one of my favorite Disney "jazzy songs": 'I wanna be like you', from The Jungle Book! I've had lots of fun doing this cover and mimicking a (somewhat ill) trumpet - and as usual, there's some artwork to go with it. I hope you'll like it 🙂 IRead More
October 26, 2020

Discover the Caliscope!

How would you like to browse paintings in an interactive and yet intuitive way on your phone? The Caliscope is an online very lightweight web app that lets you swipe through dozens of abstract paintings with only a cube… but thanks to the magic of virtualization, this cube can have more than 6 faces…
October 19, 2020

I participated in a podcast!

Hi everyone! Today, something a bit special: I recently had the chance to participate in a podcast called “CodeTalkers“. Here is the link to the recording and a quick debrief of this amazing experience. Less than a month ago, I received an out-of-the-blue email from Martin Jakubik, a developer in ro…
Show more

 LabGenius Frequently Asked Questions

  • When was LabGenius founded?

    LabGenius was founded in 2012.

  • Who are LabGenius key executives?

    LabGenius's key executives are James Field, Nan Li and Zavain Dar.

  • How many employees does LabGenius have?

    LabGenius has 46 employees.

  • Who are LabGenius competitors?

    Competitors of LabGenius include BenevolentAI, RPA Holdings and Pickle Robot.

  • Where is LabGenius headquarters?

    LabGenius headquarters is located at 100 Drummond Rd, Bermondsey, London.

  • Where are LabGenius offices?

    LabGenius has an office in London.

  • How many offices does LabGenius have?

    LabGenius has 1 office.